{"version":"1.0","provider_name":"European Scientist","provider_url":"https:\/\/www.europeanscientist.com\/en\/","author_name":"Rebecca Ochs","author_url":"https:\/\/www.europeanscientist.com\/en\/author\/rebecca-ochs\/","title":"Immunotherapy could treat prostate cancer","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"5hGcnkQZz0\"><a href=\"https:\/\/www.europeanscientist.com\/en\/public-health\/immunotherapy-could-treat-prostate-cancer\/\">Immunotherapy could treat prostate cancer<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.europeanscientist.com\/en\/public-health\/immunotherapy-could-treat-prostate-cancer\/embed\/#?secret=5hGcnkQZz0\" width=\"600\" height=\"338\" title=\"&#8220;Immunotherapy could treat prostate cancer&#8221; &#8212; European Scientist\" data-secret=\"5hGcnkQZz0\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.europeanscientist.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.europeanscientist.com\/wp-content\/uploads\/2018\/06\/syringe-1884758_1920.jpg","thumbnail_width":1920,"thumbnail_height":1152,"description":"In a new clinical trial, researchers have demonstrated for the first time that immunotherapy could be effective in treating prostate cancer. Although the therapy will not be effective for most patients, researchers hailed the results as a \u201cbig deal,\" saying the discovery could save lives."}